Technical Analysis for AGL - Angle Plc

Grade Last Price % Change Price Change
grade D 64.5 0.00% 0.00
AGL closed unchanged on Friday, January 17, 2020, on approximately normal volume.
Earnings due: Jan 29
*** please verify all earnings dates ***

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Up
Historical AGL trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Doji - Bullish? Reversal 0.00%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

ANGLE plc is a holding company. The Company's principal activity is undertaken in relation to the commercialization of its Parsortix cell separation system, with deployment in non-invasive cancer diagnostics. The Company is a specialist medical diagnostic company, which offers products for cancer diagnostics and fetal health. Its Parsortix cell separation system uses a microfluidic technology in the form of a one-time use cassette to capture and then harvest circulating tumor cells (CTCs) from blood. The cassette captures CTCs based on their less deformable nature and larger size compared to other blood components. The resulting liquid biopsy (blood test) enables the detection and investigation of mutations in the patient's cancer for personalized cancer care. The harvested CTCs have a range of applications, including diagnosis, prognosis, mutational analysis and drug selection, drug development, assessment of treatment effectiveness and remission monitoring.
Medicine Medical Specialties Cancer Clinical Medicine Drug Development Oncology Medical Diagnostic

Is AGL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 85.0
52 Week Low 51.0
Average Volume 92,070
200-Day Moving Average 69.20
50-Day Moving Average 63.52
20-Day Moving Average 62.74
10-Day Moving Average 63.97
Average True Range 1.33
ADX 27.3
+DI 18.73
-DI 18.54
Chandelier Exit (Long, 3 ATRs ) 61.88
Chandelier Exit (Short, 3 ATRs ) 64.00
Upper Bollinger Band 66.13
Lower Bollinger Band 59.35
Percent B (%b) 0.76
BandWidth 10.79
MACD Line 0.36
MACD Signal Line -0.06
MACD Histogram 0.4181
Fundamentals Value
Market Cap 37.97 Million
Num Shares 589 Thousand
EPS -0.08
Price-to-Earnings (P/E) Ratio -806.25
Price-to-Sales 0.00
Price-to-Book 383.15
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 65.44
Resistance 3 (R3) 65.38 65.01 65.28
Resistance 2 (R2) 65.01 64.77 65.04 65.23
Resistance 1 (R1) 64.76 64.63 64.81 64.81 65.18
Pivot Point 64.39 64.39 64.42 64.42 64.39
Support 1 (S1) 64.13 64.15 64.19 64.19 63.82
Support 2 (S2) 63.76 64.00 63.79 63.77
Support 3 (S3) 63.51 63.76 63.72
Support 4 (S4) 63.56